Levofloxacina Arena

Levofloxacin, the active ingredient in Levofloxacina Arena, is a fluoroquinolone antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections in adults and children when prescribed by a qualified healthcare professional.

GNH USA supplies Levofloxacina Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Arena is a fluoroquinolone antibiotic used to treat bacterial infections affecting several organ systems.

- Respiratory tract infections: effective for community‑acquired pneumonia, acute exacerbations of chronic bronchitis and other lower respiratory infections. - Urinary tract infections: clears uncomplicated and complicated UTIs caused by susceptible organisms. - Skin and soft tissue infections: treats cellulitis, wound infections and other dermal bacterial conditions. - Sinusitis: resolves acute bacterial sinus infections resistant to first‑line agents. - Prostatitis: eradicates bacterial prostatitis when appropriate.

Levofloxacina Arena may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatic toxicity: elevated liver enzymes, jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levofloxacina Arena, clinicians should consider several safety factors.

- Assess renal function: dose adjustment may be needed in renal impairment. - Review cardiac history: avoid in patients with known QT prolongation. - Monitor for tendon pain: discontinue if tendonitis or rupture is suspected. - Evaluate for hypersensitivity: avoid in patients with known fluoroquinolone allergy. - Consider pregnancy and lactation: safety data are limited; use only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Levofloxacina Arena can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of cumulative toxicity. - Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Theophylline: levofloxacin may raise plasma theophylline levels, causing toxicity. - CYP450 inducers (e.g., rifampin, carbamazepine): may lower levofloxacin concentrations, reducing effectiveness.